Anteris AMEUF Stock
Anteris Price Chart
Anteris AMEUF Financial and Trading Overview
Anteris stock price | 15.53 USD |
Previous Close | 14.6 USD |
Open | 14.85 USD |
Bid | 0 USD x 0 |
Ask | 0 USD x 0 |
Day's Range | 14.85 - 15.14 USD |
52 Week Range | 11.82 - 20.5 USD |
Volume | 1.02K USD |
Avg. Volume | 417 USD |
Market Cap | 234.41M USD |
Beta (5Y Monthly) | 0.590038 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.8 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
AMEUF Valuation Measures
Enterprise Value | 198.01M USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 51.068394 |
Price/Book (mrq) | 15.914827 |
Enterprise Value/Revenue | 43.138 |
Enterprise Value/EBITDA | -4.272 |
Trading Information
Anteris Stock Price History
Beta (5Y Monthly) | 0.590038 |
52-Week Change | 0.43% |
S&P500 52-Week Change | 20.43% |
52 Week High | 20.5 USD |
52 Week Low | 11.82 USD |
50-Day Moving Average | 14.92 USD |
200-Day Moving Average | 15.24 USD |
AMEUF Share Statistics
Avg. Volume (3 month) | 417 USD |
Avg. Daily Volume (10-Days) | 210 USD |
Shares Outstanding | 15.49M |
Float | 10.43M |
Short Ratio | N/A |
% Held by Insiders | 17.22% |
% Held by Institutions | 28.15% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | -1032.35% |
Gross Margin | 56.83% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -111.84% |
Return on Equity (ttm) | -321.70% |
Income Statement
Revenue (ttm) | 4.59M USD |
Revenue Per Share (ttm) | 0.34 USD |
Quarterly Revenue Growth (yoy) | -54.40% |
Gross Profit (ttm) | 2.61M USD |
EBITDA | -46354168 USD |
Net Income Avi to Common (ttm) | -44340160 USD |
Diluted EPS (ttm) | -2.32 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 13.81M USD |
Total Cash Per Share (mrq) | 0.99 USD |
Total Debt (mrq) | 1.41M USD |
Total Debt/Equity (mrq) | 10.64 USD |
Current Ratio (mrq) | 2.396 |
Book Value Per Share (mrq) | 0.951 |
Cash Flow Statement
Operating Cash Flow (ttm) | -38995192 USD |
Levered Free Cash Flow (ttm) | -24997556 USD |
Profile of Anteris
Country | United States |
State | QLD |
City | Toowong |
Address | Toowong Tower |
ZIP | 4066 |
Phone | 61 13 0055 0310 |
Website | https://www.anteristech.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Anteris Technologies Ltd operates as a structural heart company. It manufactures and sells ADAPT, a regenerative tissue product. The company also engages in the developing of DurAVRTM, a 3D single piece aortic valve for the treatment of aortic stenosis. In addition, it researches and develops regenerative medicines. The company was formerly known as Admedus Limited and changed its name to Anteris Technologies Ltd in May 2020. Anteris Technologies Ltd was incorporated in 1999 and is based in Toowong, Australia.
Q&A For Anteris Stock
What is a current AMEUF stock price?
Anteris AMEUF stock price today per share is 15.53 USD.
How to purchase Anteris stock?
You can buy AMEUF shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Anteris?
The stock symbol or ticker of Anteris is AMEUF.
Which industry does the Anteris company belong to?
The Anteris industry is Medical Devices.
How many shares does Anteris have in circulation?
The max supply of Anteris shares is 18.2M.
What is Anteris Price to Earnings Ratio (PE Ratio)?
Anteris PE Ratio is now.
What was Anteris earnings per share over the trailing 12 months (TTM)?
Anteris EPS is -2.8 USD over the trailing 12 months.
Which sector does the Anteris company belong to?
The Anteris sector is Healthcare.